HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Seiichi Mori Selected Research
Seiichi Mori Research Topics
Disease
24
Neoplasms (Cancer)
06/2022 - 01/2002
9
Ovarian Neoplasms (Ovarian Cancer)
01/2015 - 08/2007
4
Rectal Neoplasms (Rectal Cancer)
02/2021 - 10/2017
4
Carcinoma (Carcinomatosis)
01/2021 - 12/2010
3
Breast Neoplasms (Breast Cancer)
06/2022 - 08/2009
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 04/2013
3
Carcinogenesis
01/2011 - 09/2003
2
Neoplasm Metastasis (Metastasis)
06/2022 - 01/2012
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2018 - 12/2014
2
Lymphoma (Lymphomas)
04/2018 - 12/2014
2
Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 04/2015
1
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2022
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2021
1
Sarcoma (Soft Tissue Sarcoma)
01/2021
1
Adenocarcinoma
01/2021
1
Endometrioid Carcinoma
01/2020
1
Hyperplasia
01/2020
1
Primary Myelofibrosis (Myelosclerosis)
01/2015
1
Cysts
01/2015
1
Polycythemia Vera
01/2015
1
Burkitt Lymphoma (Burkitt's Lymphoma)
12/2014
1
Hypersensitivity (Allergy)
08/2014
1
Ovarian Epithelial Carcinoma
02/2009
1
Hydronephrosis
12/2004
Drug/Important Bio-Agent (IBA)
7
Biological Products
IBA
11/2021 - 09/2003
6
Biomarkers (Surrogate Marker)
IBA
10/2022 - 08/2007
5
Small Interfering RNA (siRNA)
IBA
01/2018 - 01/2011
4
Platinum
IBA
01/2022 - 08/2007
4
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 02/2009
4
Proteins (Proteins, Gene)
FDA Link
01/2017 - 01/2002
4
Pharmaceutical Preparations
IBA
04/2015 - 08/2009
4
Cisplatin (Platino)
FDA Link
Generic
12/2010 - 08/2007
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2022 - 01/2021
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
02/2021 - 01/2021
2
Indicators and Reagents (Reagents)
IBA
02/2021 - 01/2019
2
RNA (Ribonucleic Acid)
IBA
01/2021 - 04/2015
2
Ligands
IBA
01/2019 - 01/2018
2
Tyrosine Kinase Inhibitors
IBA
01/2018 - 01/2015
2
Dasatinib (BMS 354825)
FDA Link
01/2018 - 04/2015
2
MicroRNAs (MicroRNA)
IBA
10/2017 - 06/2010
2
Gefitinib (Iressa)
FDA Link
01/2015 - 05/2013
2
ErbB Receptors (EGF Receptor)
IBA
01/2015 - 04/2013
2
Paclitaxel (Taxol)
FDA Link
Generic
10/2014 - 05/2010
2
Transforming Growth Factor beta (TGF-beta)
IBA
01/2012 - 01/2011
2
Messenger RNA (mRNA)
IBA
06/2010 - 02/2009
1
mogamulizumab
IBA
10/2022
1
Chromatin
IBA
06/2022
1
Transposases
IBA
06/2022
1
Estrogen Receptors
IBA
06/2022
1
Phenobarbital (Luminal)
FDA Link
06/2022
1
Estrogens (Estrogen)
FDA Link
01/2020
1
Immunosorbents
IBA
01/2019
1
Enzymes
IBA
01/2019
1
Immune Checkpoint Inhibitors
IBA
01/2018
1
Histone Deacetylases (Histone Deacetylase)
IBA
01/2018
1
Claudins
IBA
01/2017
1
ASP3026
IBA
01/2016
1
Crizotinib
IBA
01/2016
1
phenothiazine
IBA
04/2015
1
Penfluridol (Semap)
IBA
04/2015
1
Thioridazine (Mellaril)
FDA Link
Generic
04/2015
1
Fingolimod Hydrochloride (FTY720)
FDA Link
04/2015
1
Therapeutic Uses
IBA
04/2015
1
Protein Phosphatase 2 (Protein Phosphatase 2A)
IBA
04/2015
1
Phosphotransferases (Kinase)
IBA
04/2015
1
Cytokines
IBA
01/2015
1
Inflammasomes
IBA
01/2015
1
Glucose (Dextrose)
FDA Link
Generic
01/2015
1
Iron
IBA
01/2015
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
08/2014
1
Transforming Growth Factor beta Receptors (TGF beta Receptors)
IBA
01/2012
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2012
1
A-83-01
IBA
01/2012
1
Resveratrol
IBA
03/2011
1
Topoisomerase Inhibitors
IBA
03/2011
1
Methyltransferases
IBA
01/2011
1
Sirtuin 2
IBA
01/2011
1
Hepatocyte Nuclear Factor 1
IBA
12/2010
1
Sorafenib (BAY 43-9006)
FDA Link
12/2010
1
7-hydroxystaurosporine (UCN 01)
IBA
05/2010
1
Simvastatin (Zocor)
FDA Link
Generic
08/2009
1
E2F Transcription Factors
IBA
02/2009
1
taxane
IBA
02/2009
1
Taxoids (Taxanes)
IBA
02/2009
1
Basic Helix-Loop-Helix Transcription Factors
IBA
12/2004
1
Bone Morphogenetic Protein 4
IBA
12/2004
1
Cyclin D1
IBA
09/2003
Therapy/Procedure
9
Therapeutics
06/2022 - 08/2009
4
Drug Therapy (Chemotherapy)
01/2022 - 02/2009
3
Neoadjuvant Therapy
02/2021 - 10/2017
2
Chemoradiotherapy
02/2021 - 01/2018
2
Radiotherapy
01/2019 - 01/2018
1
Immunotherapy
01/2021
1
Oral Administration
01/2016
1
Intraperitoneal Injections
12/2010